These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 79304)

  • 21. [Immunochemical study of the alpha-globulins in human kidney tumor tissue].
    Pchelkina ZM; Matveev BP; Rykunov EI; Terent'ev AA; Tatarinov IuS
    Vopr Med Khim; 1979; 25(4):439-41. PubMed ID: 89757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological evaluation in patients with urological cancers.
    Martinez-Piñeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary report of an immunological study in urological cancer.
    Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
    Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective monocyte function in patients with genitourinary carcinoma.
    Hausman MS; Brosman S; Snyderman R; Mickey MR; Fahey J
    J Natl Cancer Inst; 1975 Nov; 55(5):1047-54. PubMed ID: 1107568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 27. [Urologic cancer metastases. Introduction].
    Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):361-7. PubMed ID: 4807865
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
    Ackermann R
    Eur Urol; 1975; 1(3):154-6. PubMed ID: 786650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of head and neck metastases from genito-urinary neoplasms.
    Flocks RH; Boatman DL
    Laryngoscope; 1973 Sep; 83(9):1527-39. PubMed ID: 4758761
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytostatic adjuvant therapy of tumors in the urogenital region].
    Vahlensieck W
    Haematol Blood Transfus; 1978; 22():165-74. PubMed ID: 220154
    [No Abstract]   [Full Text] [Related]  

  • 33. [The diagnostic value of hyper-alpha-2 globulinemia in neoplasms of the male urinary and genital systems].
    Musiani U; Fornasari R; Vaccari E
    Cancro; 1974; 27(3):119-26. PubMed ID: 4142932
    [No Abstract]   [Full Text] [Related]  

  • 34. Irradiation and/or surgery. Some areas of confrontation in urologic oncology.
    Whitmore WF
    Am J Clin Oncol; 1984 Dec; 7(6):595-606. PubMed ID: 6099052
    [No Abstract]   [Full Text] [Related]  

  • 35. A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
    McLaughlin AP; Brooks JD
    J Urol; 1974 Sep; 112(3):366-72. PubMed ID: 4546711
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
    Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
    Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative evaluation of immunoglobulins in patients with bladder carcinoma].
    Maver A; Martinell A
    Cancro; 1969; 22(6):607-11. PubMed ID: 4104216
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
    Reynoso G; Chu TM; Guinan P; Murphy GP
    Cancer; 1972 Jul; 30(1):1-4. PubMed ID: 5064805
    [No Abstract]   [Full Text] [Related]  

  • 40. A B O (H) blood group antigen determination in genitourinary neoplasms.
    Ghazizadeh M; Kagawa S
    Tokushima J Exp Med; 1983 Jun; 30(1-2):9-16. PubMed ID: 6685361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.